True

Spot on imo 🎯 and it only got worse recently. If you take the entire R&D budget of the top 50 biopharma companies you will likely see this anomaly where a small number of MOAs capture the majority of budgets. In oncology - 20+ PD1xVEGF programs (two approved targets), 10+

Lot of groups working on AI-enabled clinical trials prediction tools lately. I'll believe it works when I see a new biotech fund that doesn't lose money this year

This is my Roman Empire. Have we made any progress on understanding role of Vaults as of late?

Big news in the muscle and metabolic health world today from Regeneron - a one-two punch. First they get a Ph3 ready GLP-1/GIP agonist for $80M upfront from Hansoh. On top of this being a potential (late) tirzepatide competitor the main unlock here is it opens up a wide range of

Excited for all the wisdom Kathleen is about to drop on TBPN who ran life sciences at Palantir

We asked Kathleen McMahon (ex-Head of Life Sciences at Palantir) about the current state of biodefense. "Two things changed recently." "Our ability to edit genomes with tools like CRISPR and AI uplift (e.g. bio-specific language models) now allows novices to create

We asked Kathleen McMahon (ex-Head of Life Sciences at Palantir) about deterring biological attacks. "There are three pillars: detection, countermeasure development, and attribution." "If you can detect a threat before an outbreak and quickly develop a countermeasure, the

😀🚗 appliedintuition.com/news/applied-i…

The magic of eGenesis: turning science fiction (employing gene editing + genome engineering to transplant pig kidneys into human beings) into everyday "life" boston25news.com/news/local/nh-…

Tim Andrews, a 67-year-old Concord, Mass. man who has been living with a xeno pig kidney for 137 days threw out the ceremonial first pitch at the Red Sox game Wednesday night.

🔥Big exciting news - I've started a new company! 🚀 We are building AI agents that take actions in the real world by orchestrating the movement of physical goods. We're working with our first partners and are now growing the founding engineering team. We're building in NYC,

Veterinary medicine is overlooked but important + sizable market. Soon will be 4 drugs approved for itch in dogs that will do billions in revenue

I’m proud to share that Maven has raised $50M in Series B funding, bringing our total raised to $78M! The round was led by Dell Technologies Capital with backing from Cisco Investments, SE Ventures (the VC firm backed by Schneider Electric), and returning investors Lux Capital,

When most people picture a "drone," they see the General Atomics iconic Predator – trusted, proven, and in service for over 30 years with more than 8 million flight hours logged. We're excited to announce our partnership with General Atomics Aeronautical Systems, Inc (GA-ASI) (GA-ASI). GA-ASI is deploying

This crewless Saildrone ship is defending Denmark’s and NATO’s waters. This is how it works. euronews.com/next/2025/06/2…

Michelle is a force of nature & the real deal. We're so lucky to have her on the team. If you don't know her yet, say hello in bay area / NYC!

We are all somatic mutation mosaics. "There are trillions of cells in a human body and so the total number of somatic mutations acquired in a single individual may well exceed quadrillions, millions of times the size of the human genome." nature nature.com/articles/s4158…

U.S. FDA just cleared Mendaera’s Focalist by Lux fam co Mendaera, Inc. 🎉‌ This novel system will transform millions of everyday medical procedures. A huge step forward for accessible robotics🦿🦾 Read more from Forbes & watch the demo 👇 forbes.com/sites/saibala/…

So proud of the entire team at Mendaera for brining Mendaera, Inc. to life! Congrats on the 510(k). This is only the beginning!